Demographic characteristics of IMMEnSE cases and controls
| Cases | Controls | ||||||
|---|---|---|---|---|---|---|---|
| Regiona | Gender M/F (total) | Mean age (±SD) | Median age (range) | Gender M/F (total) | Mean age (±SD) | Median age (range) | Control type |
| IT | 121/111 (232) | 62.5 (±9.9) | 63 (35–87) | 131/106 (237) | 58.8 (±10.8) | 59 (35–89) | General population |
| PL | 172/189 (361) | 62.2 (±10.5) | 63 (34–86) | 126/234 (360) | 50.6 (±19.5) | 49.5 (18–98) | Blood donors |
| ES | 133/137 (270) | 63.1 (±11.4) | 63 (27–75) | 229/198 (427) | 63.1 (±11.9) | 62 (24–92) | Hospitalized subjects |
| FR | 46/35 (81) | 55.5 (±9.4) | 57 (27–75) | 101/90 (191) | 43.7 (±15.5) | 48 (18–68) | Blood donors |
| PT | 32/36 (68) | 66.0 (±11.2) | 67.5 (41–86) | 55/45 (100) | 60.7 (±7.7) | 58 (51–85) | Blood donors |
| HU | 49/90 (139) | 66.2 (±11.3) | 68 (34–90) | 50/54 (104) | 73.4 (±10.1) | 74.5 (51–95) | Hospitalized subjects |
| DK | 203/144 (347) | 55.2 (±7.1) | 56 (29–69) | 293/222 (515) | 43.3 (±11.7) | 44 (17–97) | Blood donors |
| Total | 756/742 (1,498) | 60.9 (±10.6) | 61 (27–93) | 985/949 (1,934) | 62.0 (±13.3) | 63 (18–98) | |
PL (Poland): Department of Hematology, Medical University of Łodz, Łodz; Department of Hematology, Cracow University Hospital, Cracow; Rzeszow Regional Hospital, Rzeszow; Holycross Cancer Center, Kielce.
ES (Spain): Hematology Division, University Hospital of Salamanca, Salamanca; Hematology and Hemotherapy Department, University Hospital Virgen de las Nieves, Granada; IDIBELL—Catalan Institute of Oncology, CIBERESP and Barcelona University, Barcelona; Hospital Universitario Doce de Octubre, Madrid; Hospital General Universitario Morales Meseguer, Murcia.
FR (France): Hospices Civils de Lyon, Lyon; International Agency for Research on Cancer (IARC), Lyon.
PT (Portugal): Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga.
HU (Hungary): Department of Hematology, Semmelweis University, Budapest.
DK (Denmark): Department of Hematology, Roskilde Hospital, Copenhagen University, Roskilde; Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen; Department of Epidemiology, School of Public Health, Aarhus University, Aarhus; Hospital of Southern Jutland, Aabenraa/Sønderborg; University of Southern Denmark, Odense.
↵aIT (Italy): Department of Oncology, Transplants and Advanced Technologies, Section of Haematology, Pisa University Hospital, Pisa; Department of Biology, Division of Genetics, Pisa University, Pisa.